| Metabolic profile of antipsychotic-naive individuals with non-affective psychosis E Fernandez-Egea, M Bernardo, T Donner, I Conget, E Parellada, ... The British journal of psychiatry 194 (5), 434-438, 2009 | 297 | 2009 |
| Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study R Penadés, N Pujol, R Catalán, G Massana, G Rametti, C García-Rizo, ... Biological psychiatry 73 (10), 1015-1023, 2013 | 227 | 2013 |
| Resilience and mental health during the COVID-19 pandemic N Verdolini, S Amoretti, L Montejo, C García-Rizo, B Hogg, G Mezquida, ... Journal of affective disorders 283, 156-164, 2021 | 156 | 2021 |
| Glucose abnormalities in the siblings of people with schizophrenia E Fernandez-Egea, M Bernardo, E Parellada, A Justicia, C Garcia-Rizo, ... Schizophrenia research 103 (1-3), 110-113, 2008 | 120 | 2008 |
| Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, E Parellada, ... Schizophrenia research 134 (1), 16-19, 2012 | 109 | 2012 |
| Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis AM Greenhalgh, L Gonzalez-Blanco, C Garcia-Rizo, E Fernandez-Egea, ... Schizophrenia research 179, 57-63, 2017 | 104 | 2017 |
| Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY. B Solé, N Verdolini, S Amoretti, L Montejo, AR Rosa, B Hogg, ... Journal of affective disorders 281, 13-23, 2021 | 103 | 2021 |
| Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? B Kirkpatrick, BJ Miller, C Garcia-Rizo, E Fernandez-Egea, M Bernardo Schizophrenia bulletin 38 (2), 280-284, 2012 | 98 | 2012 |
| Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features C Garcia-Rizo, E Fernandez-Egea, C Oliveira, A Justicia, M Bernardo, ... Psychiatry research 198 (2), 212-215, 2012 | 96 | 2012 |
| Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naive patients with depression C Garcia-Rizo, E Fernandez-Egea, BJ Miller, C Oliveira, A Justicia, ... Brain, behavior, and immunity 28, 49-53, 2013 | 92 | 2013 |
| Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ... Frontiers in Neuroendocrinology 45, 25-34, 2017 | 89 | 2017 |
| Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: a meta-analysis L Gonzalez-Blanco, AMD Greenhalgh, C Garcia-Rizo, E Fernandez-Egea, ... Schizophrenia research 174 (1-3), 156-160, 2016 | 88 | 2016 |
| Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative … V Soria, A Gonzalez-Rodriguez, E Huerta-Ramos, J Usall, J Cobo, ... Psychoneuroendocrinology 93, 8-19, 2018 | 77 | 2018 |
| Differences in glucose tolerance between deficit and nondeficit schizophrenia B Kirkpatrick, E Fernandez-Egea, C Garcia-Rizo, M Bernardo Schizophrenia Research 107 (2-3), 122-127, 2009 | 76 | 2009 |
| Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis M Bioque, MP García-Portilla, C García-Rizo, B Cabrera, A Lobo, ... Schizophrenia Research 193, 188-196, 2018 | 74 | 2018 |
| Schizophrenia: a systemic disorder B Kirkpatrick, B Miller, C García-Rizo, E Fernandez-Egea Clinical schizophrenia & related psychoses 8 (2), 73-79, 2014 | 71 | 2014 |
| Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ... Revista de Psiquiatría y Salud Mental (English Edition) 9 (3), 158-173, 2016 | 69 | 2016 |
| Spanish adaptation and validation of the Brief Negative Symptoms Scale A Mané, C García-Rizo, MP Garcia-Portilla, D Bergé, G Sugranyes, ... Comprehensive Psychiatry 55 (7), 1726-1729, 2014 | 63 | 2014 |
| Abnormal glycemic homeostasis at the onset of serious mental illnesses: a common pathway C Garcia-Rizo, B Kirkpatrick, E Fernandez-Egea, C Oliveira, M Bernardo Psychoneuroendocrinology 67, 70-75, 2016 | 61 | 2016 |
| Metabolic effects of olanzapine in patients with newly diagnosed psychosis E Fernandez-Egea, B Miller, C Garcia-Rizo, M Bernardo, B Kirkpatrick Journal of clinical psychopharmacology 31 (2), 154-159, 2011 | 57 | 2011 |
cristina v. oliveiraBarcelona Schizophrenia Clinic Unit, Neuroscience Institute, Hospital Clinic, University of Barcelona, Barcelona, SpainDirección de correo verificada de clinic.ub.es
